| 1.29 -0.01 (-0.77%) | 09-11 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.65 | 1-year : | 1.76 |
| Resists | First : | 1.41 | Second : | 1.5 |
| Pivot price | 1.38 |
|||
| Supports | First : | 1.26 | Second : | 1.05 |
| MAs | MA(5) : | 1.31 |
MA(20) : | 1.38 |
| MA(100) : | 1.65 |
MA(250) : | 2.11 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 14.5  |
D(3) : | 13.9 |
| RSI | RSI(14): 35.9 |
|||
| 52-week | High : | 3.58 | Low : | 1.24 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ STXS ] has closed above bottom band by 8.0%. Bollinger Bands are 19.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 1.35 - 1.36 | 1.36 - 1.37 |
| Low: | 1.26 - 1.27 | 1.27 - 1.28 |
| Close: | 1.27 - 1.29 | 1.29 - 1.3 |
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
Sat, 05 Sep 2026
Stereotaxis: A Real Product Story, But The Stock Already Prices In Success (NYSE:STXS) - Seeking Alpha
Sun, 23 Aug 2026
STXS | Stereotaxis, Inc. Common Stock Financials - Revenue Breakdown - Quiver Quantitative
Wed, 19 Aug 2026
New >5% shareholder emerges in Stereotaxis (STXS) stock - Stock Titan
Mon, 17 Aug 2026
Stereotaxis Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Fri, 14 Aug 2026
Stereotaxis, Inc. SEC Filing (Aug 14, 2026) - Stock Titan
Tue, 11 Aug 2026
Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
AMEX
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|